Sign in

CIK 0002042347 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Seaport Therapeutics, Inc.

Sign in to watch
Ticker
SPTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
992235719
Phone
617-807-4062
Business address
6 TIDE STREET, SUITE 400, BOSTON, MA, 02110
  1. 4 Open-market buy Director bought 5,000 shares at $19.87 ($99,325)
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. SCHEDULE 13G Stake Statement of Beneficial Ownership
  5. SCHEDULE 13G Stake Statement of Beneficial Ownership
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. 4 Open-market buy Director bought 13,000 shares at $18.14 ($235,768)
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. SCHEDULE 13D Stake Beneficial Ownership Report
  13. SCHEDULE 13G Stake Statement of Beneficial Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 4 Conversion 10% owner acquired 16,382,534 shares (conversion)
  17. SCHEDULE 13D Stake Beneficial Ownership Report
  18. 4 Derivatives Options or other derivatives
  19. 4 Conversion Director acquired 2,731,538 shares (conversion)
  20. 4 Conversion Chief Financial Officer acquired 6,702 shares (conversion)

Page 1 of 3 · 58 filings